Metered-Dose Inhalers Market Will Help Manage Asthma & COPD Symptoms 2025-2033

The Global Metered-Dose inhalers Market reached US$ 16.6 billion in 2023 and is expected to reach US$ 24.18 billion by 2033, growing at a CAGR of 4.8% during the forecast period 2025-2033.

Metered-Dose Inhalers Market, as detailed in the DataM Intelligence report, presents a strategic overview of the industry backed by in-depth data and market trends. The study highlights the performance and positioning of major players, focusing on their offerings, pricing models, financial outcomes, and growth strategies. It serves as a concise yet insightful reference for understanding the current landscape and future direction of the market.

Get a Free Sample PDF Of This Report (Get Higher Priority for Corporate Email ID):- https://datamintelligence.com/download-sample/metered-dose-inhalers-market?kb

Market Overview:

Metered-Dose Inhalers (MDIs) are handheld devices used to deliver a specific amount of medication directly into the lungs, commonly for asthma or chronic obstructive pulmonary disease (COPD). They use a propellant to disperse the medication as a fine mist for rapid respiratory relief.

List of the Key Players in the Metered-Dose Inhalers Market:

Sunovion Pharmaceuticals Inc, AstraZeneca, Boehringer Ingelheim, Covis Pharma B.V., GlaxoSmithKline, Kindeva Drug Delivery LP, Teva Phamrmaceuticals, Norton Waterford LTD, Armstrong Pharmaceuticals Inc, Cipla LTD and among others.

Metered-Dose Inhalers Market Development:

In November 2023, GSK plc announced plans to initiate Phase III clinical trials in 2024 for a low-carbon version of its Ventolin (salbutamol) metered-dose inhaler. If successful, the new inhaler could cut greenhouse gas emissions by approximately 90%, significantly advancing GSK's journey toward its net-zero climate goals. Currently used by around 35 billion patients worldwide, Ventolin contributes to 49% of GSK's total carbon footprint, highlighting the substantial environmental impact of inhaler propellants across global healthcare systems.

In September 2024, AstraZeneca completed development studies for Breztri/Trixeo Aerosphere, its triple-combination therapy for COPD, using a new propellant with 99.9% lower Global Warming Potential than current inhaler propellants. Breztri will be the first medicine in AstraZeneca's pressurised metered-dose inhaler (pMDI) portfolio to make this transition. The company has also launched clinical programs to adopt the new low-impact propellant across its broader pMDI product line.

Speak to Our Senior Analyst and Get Customization in the report as per your requirements: https://datamintelligence.com/customize/metered-dose-inhalers-market?kb

Segment Covered in the Metered-Dose Inhalers Market:

By Product Type: Breath-Actuated Pressurized Inhalers, Manually-Actuated Pressurized Inhalers, Soft Mist Inhalers

By Application: Asthma, Chronic Obstructive Pulmonary Disease (COPD), Others)

By End User: Hospital Pharmacies, Retail Pharmacies, Online Pharmacies

Regional Analysis for Metered-Dose Inhalers Market:

⇥ North America (U.S., Canada, Mexico)

⇥ Europe (U.K., Italy, Germany, Russia, France, Spain, The Netherlands and Rest of Europe)

⇥ Asia-Pacific (India, Japan, China, South Korea, Australia, Indonesia Rest of Asia Pacific)

⇥ South America (Colombia, Brazil, Argentina, Rest of South America)

⇥ Middle East & Africa (Saudi Arabia, U.A.E., South Africa, Rest of Middle East & Africa)

Frequently asked questions:

➠ What are the global sales, production, consumption, import, and export figures for the Metered-Dose Inhalers market?

➠ Who are the key global manufacturers, and how are they performing operationally?

➠ What opportunities and risks do vendors face in the Metered-Dose Inhalers market?

➠ Which product types or end-users show the most growth potential, and what are their market shares?

➠ What factors are driving or limiting growth in the Metered-Dose Inhalers market?

Stay informed with the latest industry insights-start your subscription now: https://www.datamintelligence.com/reports-subscription?kb

Contact Us -

Company Name: DataM Intelligence

Contact Person: Sai Kiran

Email: Sai.k@datamintelligence.com

Phone: +1 877 441 4866

Website: https://www.datamintelligence.com

About Us -

DataM Intelligence is a Market Research and Consulting firm that provides end-to-end business solutions to organizations from Research to Consulting. We, at DataM Intelligence, leverage our top trademark trends, insights and developments to emancipate swift and astute solutions to clients like you. We encompass a multitude of syndicate reports and customized reports with a robust methodology.

Our research database features countless statistics and in-depth analyses across a wide range of 6300+ reports in 40+ domains creating business solutions for more than 200+ companies across 50+ countries; catering to the key business research needs that influence the growth trajectory of our vast clientele.

This release was published on openPR.